Unique topics and issues in rheumatology and clinical immunology.

about

CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.

P2860

Q38350065-E96757D3-1B5C-478A-BB04-36F98DCEB622

P2860

Unique topics and issues in rheumatology and clinical immunology.

Item

http://www.wikidata.org/entity/Q46941311

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Unique topics and issues in rheumatology and clinical immunology.

@en

Unique topics and issues in rheumatology and clinical immunology.

@nl

type

Item

label

Unique topics and issues in rheumatology and clinical immunology.

@en

Unique topics and issues in rheumatology and clinical immunology.

@nl

prefLabel

Unique topics and issues in rheumatology and clinical immunology.

@en

Unique topics and issues in rheumatology and clinical immunology.

@nl

P1476

Unique topics and issues in rheumatology and clinical immunology.

@en

P2860

PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses

Cogan's syndrome: an autoimmune inner ear disease

FOXP3: genetic and epigenetic implications for autoimmunity

Rethinking mechanisms of autoimmune pathogenesis

Biologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.

Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder?

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, pla

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phas

Contact allergy to corticosteroids.

Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies.

P2888

s12016-014-8441-z

P304

1-5

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-014-8441-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Carlo Selmi

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25086643

http://www.w3.org/2001/XMLSchema#string

Unique topics and issues in rheumatology and clinical immunology.

about

P2860

P2860

Unique topics and issues in rheumatology and clinical immunology.

description

name

type

label

prefLabel

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698